• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

湿疹的治疗:皮质类固醇及其他方法。

Treatment of Eczema: Corticosteroids and Beyond.

作者信息

Chong Melanie, Fonacier Luz

机构信息

Rheumatology, Allergy & Immunology, Winthrop University Hospital, 120 Mineola Blvd, Suite 410, Mineola, NY, 11501, USA.

出版信息

Clin Rev Allergy Immunol. 2016 Dec;51(3):249-262. doi: 10.1007/s12016-015-8486-7.

DOI:10.1007/s12016-015-8486-7
PMID:25869743
Abstract

Atopic dermatitis (AD) is a chronic inflammatory skin condition that requires a manifold approach to therapy. The goal of therapy is to restore the function of the epidermal barrier and to reduce skin inflammation. This can be achieved with skin moisturization and topical anti-inflammatory agents, such as topical corticosteroids and calcineurin inhibitors. Furthermore, proactive therapy with twice weekly use of both topical corticosteroids and calcineurin inhibitors in previously affected areas has been found to reduce the time to the next eczematous flare. Adjunctive treatment options include wet wrap therapy, anti-histamines, and vitamin D supplementation. Bacterial colonization, in particular Staphylococcus aureus, can contribute to eczematous flares and overt infection. Use of systemic antibiotics in infected lesions is warranted; however, empiric antibiotics use in uninfected lesions is controversial. Local antiseptic measures (i.e., bleach baths) and topical antimicrobial therapies can be considered in patients with high bacterial colonization. Difficult-to-treat AD is a complex clinical problem that may require re-evaluation of the initial diagnosis of AD, especially if the onset of disease occurs in adulthood. It may also necessitate evaluation for contact, food, and inhaled allergens that may exacerbate the underlying AD. There are a host of systemic therapies that have been successful in patients with difficult-to-treat AD, however, these agents are limited by their side effect profiles. Lastly, with further insight into the pathophysiology of AD, new biological agents have been investigated with promising results.

摘要

特应性皮炎(AD)是一种慢性炎症性皮肤病,需要采取多种治疗方法。治疗的目标是恢复表皮屏障功能并减轻皮肤炎症。这可以通过皮肤保湿和局部抗炎药物来实现,如局部用皮质类固醇和钙调神经磷酸酶抑制剂。此外,已发现对先前受累部位每周两次同时使用局部皮质类固醇和钙调神经磷酸酶抑制剂进行预防性治疗可减少下次湿疹发作的时间。辅助治疗选择包括湿敷疗法、抗组胺药和补充维生素D。细菌定植,尤其是金黄色葡萄球菌,可导致湿疹发作和明显感染。在感染病灶中使用全身性抗生素是必要的;然而,在未感染病灶中经验性使用抗生素存在争议。对于细菌定植率高的患者,可考虑采取局部抗菌措施(如漂白浴)和局部抗菌治疗。难治性AD是一个复杂的临床问题,可能需要重新评估AD的初始诊断,尤其是如果疾病在成年期发病。还可能需要评估可能加重潜在AD的接触性、食物性和吸入性过敏原。有许多全身治疗方法已在难治性AD患者中取得成功,然而,这些药物受到其副作用的限制。最后,随着对AD病理生理学的进一步深入了解,已对新型生物制剂进行了研究并取得了有前景的结果。

相似文献

1
Treatment of Eczema: Corticosteroids and Beyond.湿疹的治疗:皮质类固醇及其他方法。
Clin Rev Allergy Immunol. 2016 Dec;51(3):249-262. doi: 10.1007/s12016-015-8486-7.
2
Long-Term Treatment of Atopic Dermatitis.特应性皮炎的长期治疗
Dermatol Clin. 2017 Jul;35(3):335-349. doi: 10.1016/j.det.2017.02.007. Epub 2017 May 6.
3
Atopic dermatitis: skin care and topical therapies.特应性皮炎:皮肤护理与局部治疗
Semin Cutan Med Surg. 2017 Sep;36(3):104-110. doi: 10.12788/j.sder.2017.035.
4
ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis.ETFAD/EADV 特应性皮炎工作组 2009 年关于特应性皮炎诊断和治疗的立场文件。
J Eur Acad Dermatol Venereol. 2010 Mar;24(3):317-28. doi: 10.1111/j.1468-3083.2009.03415.x. Epub 2009 Aug 31.
5
Adjunctive Management of Itch in Atopic Dermatitis.特应性皮炎瘙痒的辅助治疗
Dermatol Clin. 2017 Jul;35(3):373-394. doi: 10.1016/j.det.2017.02.011. Epub 2017 May 6.
6
[Diagnostic, prophylactic and therapeutic guidelines in patients with atopic dermatitis. Position paper by the task force of the National Specialists on Dermatology, Venereology and Allergology].[特应性皮炎患者的诊断、预防和治疗指南。国家皮肤科、性病学和过敏学专家工作组立场文件]
Pol Merkur Lekarski. 2004;17 Suppl 3:3-15.
7
Treatment strategies for atopic dermatitis: optimizing the available therapeutic options.特应性皮炎的治疗策略:优化现有治疗选择。
Semin Cutan Med Surg. 2012 Sep;31(3 Suppl):S10-7. doi: 10.1016/j.sder.2012.07.004.
8
Clinical management of atopic dermatitis: practical highlights and updates from the atopic dermatitis practice parameter 2012.特应性皮炎的临床管理:2012年特应性皮炎实践参数的实用要点与更新
J Allergy Clin Immunol Pract. 2014 Jul-Aug;2(4):361-9; quiz 370. doi: 10.1016/j.jaip.2014.02.015. Epub 2014 Apr 25.
9
Atopic dermatitis: an overview.特应性皮炎概述。
Am Fam Physician. 2012 Jul 1;86(1):35-42.
10
Diagnosis and Management of Dermatitis, Including Atopic, Contact, and Hand Eczemas.皮炎的诊断和管理,包括特应性皮炎、接触性皮炎和手部湿疹。
Med Clin North Am. 2021 Jul;105(4):611-626. doi: 10.1016/j.mcna.2021.04.003.

引用本文的文献

1
Synergistic Combinations of Native Australian Plants For Skin Inflammation and Wound Healing.澳大利亚本土植物对皮肤炎症和伤口愈合的协同组合
Biomedicines. 2025 Jul 17;13(7):1754. doi: 10.3390/biomedicines13071754.
2
Mānuka oil based ECMT-154 versus vehicle control for the topical treatment of eczema: study protocol for a randomised controlled trial in community pharmacies in Aotearoa New Zealand.基于麦卢卡油的 ECMT-154 与载体对照治疗湿疹的局部治疗:新西兰社区药房中一项随机对照试验的研究方案。
BMC Complement Med Ther. 2024 Jan 29;24(1):61. doi: 10.1186/s12906-024-04358-9.
3
Epidemiology and healthcare resource utilization in atopic dermatitis in Colombia: A retrospective analysis of data from the National Health Registry from 2015 to 2020.

本文引用的文献

1
The role of antiseptic agents in atopic dermatitis.抗菌剂在特应性皮炎中的作用。
Asia Pac Allergy. 2014 Oct;4(4):230-40. doi: 10.5415/apallergy.2014.4.4.230. Epub 2014 Oct 29.
2
Randomized trial of vitamin D supplementation for winter-related atopic dermatitis in children.随机对照试验维生素 D 补充剂治疗儿童冬季相关特应性皮炎。
J Allergy Clin Immunol. 2014 Oct;134(4):831-835.e1. doi: 10.1016/j.jaci.2014.08.002.
3
Identification of novel gene signatures in patients with atopic dermatitis complicated by eczema herpeticum.
哥伦比亚特应性皮炎的流行病学和医疗资源利用情况:对 2015 年至 2020 年国家健康登记处数据的回顾性分析。
Biomedica. 2023 Mar 30;43(1):107-120. doi: 10.7705/biomedica.6666.
4
Short-term exposure of PM and PM increases the number of outpatients with eczema in Guangzhou: A time-series study.短期 PM 和 PM 暴露会增加广州湿疹患者的门诊人数:一项时间序列研究。
Front Public Health. 2023 Feb 21;10:930545. doi: 10.3389/fpubh.2022.930545. eCollection 2022.
5
Cytochrome P450 3A4 suppression by epimedium and active compound kaempferol leads to synergistic anti-inflammatory effect with corticosteroid.淫羊藿及其活性成分山奈酚对细胞色素P450 3A4的抑制作用可导致与皮质类固醇产生协同抗炎效应。
Front Pharmacol. 2023 Jan 30;13:1042756. doi: 10.3389/fphar.2022.1042756. eCollection 2022.
6
Network Pharmacology Integrated with Transcriptomics Analysis Reveals Ermiao Wan Alleviates Atopic Dermatitis via Suppressing MAPK and Activating the EGFR/AKT Signaling.网络药理学与转录组学分析揭示二妙丸通过抑制 MAPK 和激活 EGFR/AKT 信号通路缓解特应性皮炎
Drug Des Devel Ther. 2022 Dec 21;16:4325-4341. doi: 10.2147/DDDT.S384927. eCollection 2022.
7
L. extracts alleviate 2,4-dinitrochlorobenzene-induced atopic dermatitis in mice.L提取物可减轻2,4-二硝基氯苯诱导的小鼠特应性皮炎。
Front Nutr. 2022 Aug 16;9:986943. doi: 10.3389/fnut.2022.986943. eCollection 2022.
8
Efficacy of a 3% Kānuka oil cream for the treatment of moderate-to-severe eczema: A single blind randomised vehicle-controlled trial.3%卡努卡油乳膏治疗中重度湿疹的疗效:一项单盲随机赋形剂对照试验。
EClinicalMedicine. 2022 Jul 15;51:101561. doi: 10.1016/j.eclinm.2022.101561. eCollection 2022 Sep.
9
Molecular and cellular mechanisms of itch and pain in atopic dermatitis and implications for novel therapeutics.特应性皮炎中瘙痒和疼痛的分子与细胞机制及其对新型疗法的意义
Clin Transl Immunology. 2022 May 9;11(5):e1390. doi: 10.1002/cti2.1390. eCollection 2022.
10
Update on the Pathogenesis and Therapy of Atopic Dermatitis.特应性皮炎发病机制和治疗的最新进展。
Clin Rev Allergy Immunol. 2021 Dec;61(3):324-338. doi: 10.1007/s12016-021-08880-3. Epub 2021 Aug 2.
伴有疱疹样湿疹的特应性皮炎患者中新型基因特征的鉴定。
J Allergy Clin Immunol. 2014 Oct;134(4):848-55. doi: 10.1016/j.jaci.2014.07.018. Epub 2014 Aug 23.
4
The use of biologicals in cutaneous allergies - present and future.生物制剂在皮肤过敏中的应用——现状与未来。
Curr Opin Allergy Clin Immunol. 2014 Oct;14(5):409-16. doi: 10.1097/ACI.0000000000000096.
5
Wet wrap therapy in children with moderate to severe atopic dermatitis in a multidisciplinary treatment program.多学科治疗方案中针对中重度特应性皮炎患儿的湿敷疗法
J Allergy Clin Immunol Pract. 2014 Jul-Aug;2(4):400-6. doi: 10.1016/j.jaip.2014.04.009.
6
Recurrent MRSA skin infections in atopic dermatitis.特应性皮炎中的复发性耐甲氧西林金黄色葡萄球菌皮肤感染
J Allergy Clin Immunol Pract. 2014 Jul-Aug;2(4):396-9. doi: 10.1016/j.jaip.2014.04.007. Epub 2014 May 23.
7
The role of contact dermatitis in patients with atopic dermatitis.接触性皮炎在特应性皮炎患者中的作用。
J Allergy Clin Immunol Pract. 2014 Jul-Aug;2(4):382-7. doi: 10.1016/j.jaip.2014.05.004.
8
Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents.特应性皮炎管理指南:第 3 节。光疗和全身药物治疗与管理。
J Am Acad Dermatol. 2014 Aug;71(2):327-49. doi: 10.1016/j.jaad.2014.03.030. Epub 2014 May 9.
9
Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology.环孢素治疗特应性皮炎患者可调节激活的炎症通路并逆转表皮病理学改变。
J Allergy Clin Immunol. 2014 Jun;133(6):1626-34. doi: 10.1016/j.jaci.2014.03.003. Epub 2014 Apr 29.
10
The proactive wet-wrap method with diluted corticosteroids versus emollients in children with atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled trial.糖皮质激素稀释剂主动湿式包扎法对比润肤剂治疗特应性皮炎患儿:一项前瞻性、随机、双盲、安慰剂对照试验。
J Am Acad Dermatol. 2014 Jun;70(6):1076-82. doi: 10.1016/j.jaad.2014.01.898. Epub 2014 Mar 31.